InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Avagliano Mark, Directeur Commercial. Insider active across 1 company, notably G1 Therapeutics, Inc.. In total, 9 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €42k. Activity tracked since 3 January 2022. The latest transaction was filed on 5 July 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Avagliano Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
20,600 股Common StockSEC:0000950170-24-107795:0
2,638 股@ US$2.507714.5% 占其流量Common StockSEC:0001562180-24-005657:0
35,000 股0Common StockSEC:0001562180-24-005605:0
8,151 股@ US$4.788885.5% 占其流量Common StockSEC:0001562180-24-004057:0
100,000 股0Common StockSEC:0001562180-24-002949:0
44,760 股0Common StockSEC:0001562180-24-000323:0
35,000 股0Common StockSEC:0001562180-23-004098:0
20,600 股0Common StockSEC:0001562180-23-000251:0
12,000 股0Common StockSEC:0001562180-22-000303:0
9 条申报中的 9 条
About Avagliano Mark
Avagliano Mark is Directeur Commercial and Chief Business Officer at G1 Therapeutics, Inc. Across the 9 filings recorded, the 9 sampled filings run from 2022-01-05 to 2024-09-18, with 0 in purchases and 42283 in sales, and the modal transaction nature is Attribution.
